ZBIO R&D to Revenue

Zenas Biopharma Inc · R&D to Revenue

ZBIO logo

ZBIO R&D to Revenue

Latest reported1680.63%
ZBIO FY R&D/Revenue (0.00% → 1680.63%)
High-resolution chart · PNG

ZBIO r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Zenas Biopharma Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
1,680.63%
2,782.78%
120.066%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.